Top Abstract Purchase Related
Home
>
Node
>
Subnode

Management of refractory ankylosing spondylitis and related spondyloarthropathies

Amor, B.; Dougados, M.; Khan, M.A.

Rheumatic Diseases Clinics of North America 21(1): 117-128

1995

ISSN/ISBN: 0889-857X
PMID: 7732163
Document Number: 453334
Ankylosing spondylitis is the prototype of an interrelated group of disorders termed spondyloarthropathies, which include reactive arthritis, psoriatic arthritis, and rheumatic disorders associated with inflammatory bowel disease. It can be difficult to differentiate between these disorders because they may occur simultaneously or sequentially. In addition, some of the clinical characteristics of these diseases, such as enthesiopathy and eye involvement, are similar no matter what the diagnosis. The monitoring, diagnosis, and treatment of these diseases are related more to their clinical presentation than to the precise diagnosis.

Document emailed within 1 workday
Secure & encrypted payments

Almodóvar, R.; Font, P.; Zarco-Montejo, P.; Collantes, E.; Mulero, J.; Gratacós, J.; Juanola, X.; Ariza, R. 2011: Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER) Clinical and Experimental Rheumatology 29(5): 822-827
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Gratacós, J.; Moreno Martínez-Losa, M.; Font, P.; Montilla, C.; Fernández-Espartero, C.; Linares, L.F.; Brito, E.; Oliva, J.C.; Collantes-Estevez, E. 2016: Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs? Clinical and Experimental Rheumatology 34(1): 94-99
Wei, J.C.-C.; Chan, T.W.; Lin, H.-S.; Huang, F.; Chou, C.-T. 2003: Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial Journal of Rheumatology 30(12): 2627-2631
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Huang, Z.; Cao, J.; Li, T.; Zheng, B.; Wang, M.; Zheng, R. 2011: Efficacy and safety of ultrasound-guided local injections of etanercept into entheses of ankylosing spondylitis patients with refractory Achilles enthesitis Clinical and Experimental Rheumatology 29(4): 642-649
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Jajić, Z.; Jajić, I.; Dubravica, M.; Sisek, M.; Serbo, B. 1994: Analysis of the location of pain related to sacroiliitis in ankylosing spondylitis Reumatizam 41(1): 1-3
Calabro, J.J.; Eyvazzadeh, C.; Weber, C.A. 1986: Contemporary management of ankylosing spondylitis Comprehensive Therapy 12(9): 11-18
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Healey, L.A. 1970: Notes on joint diseases. II. The management of ankylosing spondylitis Northwest Medicine 69(3): 165-166
Calabro, J.J. 1977: Arthritis of the spine: early diagnosis and management of ankylosing spondylitis Medical Times 105(11): 80-96
Darmawan, J.; Nasution, A.Remy.; Chen, S-Le.; Haq, S.Atiqul.; Zhao, D.; Zeng, Q.; Davatchi, F. 2006: Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases Journal of Rheumatology 33(12): 2484-2492
Veys, E.M.; Verbruggen, G.; Hermanns, P.; Mielants, H.; Van Bruwaene, P.; De Brabanter, G.; De Landsheere, D.; Immesoete, C. 1983: Peripheral blood T lymphocytes subpopulations in HLA-B7 related rheumatic diseases: ankylosing spondylitis and reactive synovitis Journal of Rheumatology 10(1): 140-143
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Haywood, K.L.; Garratt, A.M.; Dziedzic, K.; Dawes, P.T. 2003: Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index Journal of Rheumatology 30(4): 764-773
Rodrigues, J.; Rodrigues, A.M.; Dias, S.S.; Sousa, R.D.; Branco, J.C.; Canhão, H. 2019: Psoriatic arthritis and ankylosing spondylitis impact on health-related quality of life and working life: a comparative population-based study Acta Reumatologica Portuguesa 44(4): 254-265
Costa, T.; Falcão, S.; Mateus, M.; Branco, J. 2018: More than Ankylosing Spondylitis Acta Reumatologica Portuguesa 2018